Document Detail


Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus.
MedLine Citation:
PMID:  23340864     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
In vitro studies demonstrate that oxacillin minimal inhibitory concentrations (MICs) of methicillin-resistant S. aureus (MRSA) strains USA300 and 400 decrease in the presence of cefoxitin. The aim of this study was to characterize the activity of cefoxitin plus β-lactams against a collection of MRSA isolates. We assessed the in vitro antimicrobial activity of a selection of β-lactams alone and together with subinhibitory concentrations of cefoxitin against a collection of MRSA, methicillin-susceptible S. aureus (MSSA), and vancomycin-intermediate S. aureus (VISA) isolates using MICs and time kill assays. For community-associated (CA) MRSA strains USA300 and USA400, MICs of nafcillin, cefazolin, cephalexin, cefuroxime, ceftriaxone and cefotaxime decreased by 8- to 64-times in the presence of 10 μg/ml cefoxitin. In contrast, for hospital-associated (HA) strains COLn, N315, and Mu50, there was no change in any β-lactam MIC in the presence of cefoxitin. When combined with cefoxitin, the cephalexin MIC decreased for eight CA-MRSA and five MSSA sequence types but did not change for seven HA-MRSA sequence types. β-lactam/cefoxitin combinations were synergistic against CA- but not HA-MRSA strains in time kill assays. Cefoxitin combined with a variety of β-lactams enhances their activity against CA-MRSA strains in vitro. Further studies of combination β-lactam therapy may provide insight into β-lactam biology, penicillin binding protein cooperativity, and novel therapeutic strategies against MRSA.
Authors:
R Banerjee; M G Fernandez; N Enthaler; C Graml; K E Greenwood-Quaintance; R Patel
Related Documents :
21331554 - Biofilm formation by paenibacillus polymyxa strains differing in the production and rhe...
21774864 - Novel sequence types (sts) of staphylococcus aureus isolates causing clinical and subcl...
22080204 - Enhanced production of β-carotene by recombinant industrial wine yeast using grape jui...
16337764 - A detailed phenotypic and genotypic description of pseudomonas strain ox1.
18297444 - The antagonistic effects of a combination of vancomycin and minocycline in staphylococc...
21296924 - A multilocus sequence analysis (mlsa) approach to halobacteriales phylogeny and taxonomy.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-23
Journal Detail:
Title:  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology     Volume:  -     ISSN:  1435-4373     ISO Abbreviation:  Eur. J. Clin. Microbiol. Infect. Dis.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804297     Medline TA:  Eur J Clin Microbiol Infect Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Pediatric Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA, Banerjee.ritu@mayo.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of clinical spectrum, inoculum size and physician characteristics on sensitivity of a rapid a...
Next Document:  Lipopolysaccharide-induced failure of the gut barrier is site-specific and inhibitable by growth hor...